Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Stratum Nutrition, OraTicx Sign Exclusive Distribution Agreement for Oral Probiotics - Nutraceuticals World

What are you searching for?

Sign in
Market Updates, Products & Ingredients

Stratum Nutrition, OraTicx Sign Exclusive Distribution Agreement for Oral Probiotics

The live strains and their postbiotic forms are clinically evidenced to support an oral microbiome balance, measures of dental health, and fresh breath.

Author Image

By: Mike Montemarano

Associate Editor, Nutraceuticals World

Stratum Nutrition, a U.S. ingredient supplier, has entered into an exclusive distribution agreement with OraTicx, a Korean oral probiotic specialist. Stratum will be the sole distributor of OraTicx’s products, which include live strains of oraCMU (Weissela cibaria CMU) and oraCMS1 (Weissella cibaria CMS1), as well as the postbiotic form of oraCMU across North America.
 
OraTicx’s probiotic formulations are designed to support oral and overall health, with multiple clinical studies supporting oraCMU’s ability to benefit oral microbiome balance while promoting dental health and fresh breath. In a recent randomized, double-blind, placebo-controlled clinical trial, volunteers in the treatment group had significant improvements in breath scores and a reduced presence of compounds that produce bad breath.
 
The same benefit was also shown in two canine clinical trials, the company reported. OraCMS1 has demonstrated potential immune support benefits in addition to an impact on measures of oral health in human clinical trials, while the postbiotic version of oraCMU has been supported via an in vitro mechanism of action study.
 
“OraTicx’s high-quality oral probiotics will further strengthen our portfolio of clinically proven ingredients,” said Micah Osborne, CEO of Stratum Nutrition. “We are pleased to offer more diverse and effective health solutions to North American consumers in both human and pet markets through this partnership.”
 
“This exclusive distribution agreement with Stratum Nutrition is an important opportunity for us to introduce our innovative oral probiotics to North American consumers,” said Eun-Seop Yoon, CEO of OraTicx. “By combining the expertise of both companies, we will create new value in the North American health functional food market and grow into a global leading company that contributes to a healthy life.”

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics